Spine Biologics Market Share will Increase US$ 2.5 Billion By 2022

1. Spine Biologics Market Share will Increase US$ 2.5 Billion By2022 • Market Research Engine has published a new report titled as “Spine Biologics Market By Product Analysis (Bone graft substitutes, Platelet rich plasma (PRP), Bone grafts, Bone marrow aspirates concentrate (BMAC) therapy); By Surgery Analysis (Anterior cervical discectomy and fusion (ACDF), Anterior lumbar interbody fusion (ALIF), Transforaminal lumbar interbody fusion (TLIF), Lateral lumbar interbody fusion (LLIF)) and By Regional Analysis – Global Forecast by 2016 -2022”. • A biologic is a material which energetically alters its surrounding atmosphere and effects a change during a biological process. Spine biologics are used through spine fusion surgical procedure for the treatment of spinal defect includes wound, degenerative disc disease, tumors, and spinal cord injuries and wounds by stimulating bone expansion formation through inflammatory repair stage, stage and remodeling stage. Therefore flow in the quantity of spinal fusion surgeries has fueled the acceptance ofbiologics. • The Global Spine Biologics Market is expected to exceed more than US$ 2.6 Billion by 2022, at a CAGR of 4.4% in the given forecastperiod. • You Can Browse Full Research Report: https://www.marketresearchengine.com/spine- biologics-market • The major driving factors of Global Spine Biologics Market are asfollows: • Innovative technological advancements • Advantages of biologics include faster recovery, minimal postoperative time and ability to activate cellularexpansion. • Demand of minimally invasive spine surgeries is growing • Increasing ageing population • Incidences of spinal disorders areraising • Newly developed spine treatment techniques anddevices • The restraining factors of Global Spine Biologics Market are asfollows: • Unfavorable reimbursement policy • High cost of bonegrafts • Ethical issues associated to bone graftingprocedures • Lack of professionalexpertise • Lack of patient awareness andknowledge

2. The Global Spine Biologics Market is segmented on the lines of its product, surgery and regional. Based on product segmentation it covers bone graft substitutes, platelet rich plasma (PRP), bone grafts and bone marrow aspirate concentrate (BMAC) therapy. Under surgery segmentation it contains anterior cervical discectomy and fusion (ACDF), anterior lumbar interbody fusion (ALIF), Transforaminal lumbar interbody fusion (TLIF), lateral lumbar interbody fusion (LLIF) and other surgeries. The Global Spine Biologics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries. This report provides: An overview of the global market for Spine Biologics and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. Identifications of new market opportunities and targeted promotional plans for Global Spine BiologicsMarket. Discussion of research and development, and the demand for new products and new applications. Comprehensive company profiles of major players in theindustry. REPORT SCOPE: The scope of the report includes a detailed study of global and regional markets for Global Spine Biologics Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include DePuy Spine, Precision Spine, Medtronic, Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., Zimmer Spine Inc., K2M, Nuvasive, Arthrex, Inc., DMP Spine, Alphatec Spine, Orthofix Holdings, RTI Surgical, Wright Medical Technology, Cesca Therapeutics, and Lattice Biologics. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Global Spine Biologics Markethas been segmented asbelow:

3. By ProductAnalysis • Bone graft substitutes • Platelet rich plasma(PRP) • Bone grafts • Bone marrow aspirates concentrate (BMAC)therapy. • By SurgeryAnalysis • Anterior cervical discectomy and fusion (ACDF) • Anterior lumbar interbody fusion (ALIF) • Transforaminal lumbar interbody fusion (TLIF) • Lateral lumbar interbody fusion (LLIF) • Other surgeries • By Regional Analysis • North America • Europe • Asia-Pacific • Rest of the World • You Can Browse Full Research Report: https://www.marketresearchengine.com/spine- biologics-market Table ofContents INTRODUCTION ResearchMethodology ExecutiveSummary MarketOverview Spine Biologics Market, By SurgeryType 6 Spine Biologics Market By Product Type 7 Spine Biologics Market, ByGeography 8 CompetitiveLandscape

4. Company Profiles • Zimmer Holding, Inc. • Depuy Synthes • Medtronic, Inc. (U.S.) • Nuvasive, Inc. • Stryker Corporation • Orthofix InternationalN.V. • K2M,Inc. • Exactech,Inc. • Wright Medical Technology, Inc. • Nutech • Arthrex,Inc. • X-Spine Systems, Inc. (Bacterin International Holdings,Inc.) • DR PRP USA LLC MediaContact Contact Person: JohnBay Email: john@marketresearchengine.com Phone: +1-855-984-1862 Country: UnitedStates Website: https://www.marketresearchengine.com